Autologous ex vivo expanded regulatory CD8+ T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous ex vivo expanded regulatory CD8+ T cells, covering 2025-01-16 to 2025-01-16. Get the full timeline:
Most recent: Clinical Trial Update: Eight-Treg Study:Trial of Adoptive Immunotherapy With Autologous ex Vivo Expanded Regulatory CD8+ T Cells in Living Donor Kidney Transplant Recipients [Phase 1]